Currently, the core registration studies to assess the efficacy of retatrutide include: TRIUMPH-1 : A randomized, double-blind, placebo-controlled trial to test the safety and effectiveness of a treatment for people with obesity or overweight, including those with OSA and OA, but without type 2 diabetes
It is a primary determinant of strength, mobility, functional reserve and, in observational trials, independence
MD-Update, a Kentucky and Southern Indiana medical publication, estimated in 2024 that there were about 900,000 Kentuckians, including 29,000 children, with eating disorders
Molecules 25 (18), 4214
Rheumatologic complications of checkpoint inhibitor immunotherapy
Ibuprofen blocks prostaglandins that normally protect the stomach from acid damage, creating a compounding risk in patients whose digestive systems are adjusting to a new medication